Reference |
---|
Xiao X, Cheng Y, Zheng X, Fang Y, Zhang Y, Sun R, et al. Bispecific NK-cell engager targeting BCMA elicits stronger antitumor effects and produces less proinflammatory cytokines than T-cell engager. Front Immunol. 2023;14:1113303 pubmed publisher
|
Krohl P, Fine J, Yang H, VanDyke D, Ang Z, Kim K, et al. Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach. Cell Rep Methods. 2023;3:100429 pubmed publisher
|
Liu H, Wu L, Liu B, Xu K, Lei W, Deng J, et al. Two pan-SARS-CoV-2 nanobodies and their multivalent derivatives effectively prevent Omicron infections in mice. Cell Rep Med. 2023;4:100918 pubmed publisher
|
Zenke S, Sica M, Steinberg F, Braun J, Zink A, Gavrilov A, et al. Differential trafficking of ligands trogocytosed via CD28 versus CTLA4 promotes collective cellular control of co-stimulation. Nat Commun. 2022;13:6459 pubmed publisher
|
Chen R, Xie H, Khorsandzadeh S, Smith M, Shaabani N, Hu Q, et al. Delivering an mRNA vaccine using a lymphatic drug delivery device improves humoral and cellular immunity against SARS-CoV-2. J Mol Cell Biol. 2022;14: pubmed publisher
|
. Screening and Identification of a Novel Anti-Siglec-15 Human Antibody 3F1 and Relevant Antitumor Activity. Mol Pharmacol. 2022;102:161-171 pubmed publisher
|
Studniberg S, Ioannidis L, Utami R, Trianty L, Liao Y, Abeysekera W, et al. Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria. Mol Syst Biol. 2022;18:e10824 pubmed publisher
|
Park J, Cheung N. Overcoming tumor heterogeneity by ex vivo arming of T cells using multiple bispecific antibodies. J Immunother Cancer. 2022;10: pubmed publisher
|
Kimura I, Kosugi Y, Wu J, Zahradník J, Yamasoba D, Butlertanaka E, et al. The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance. Cell Rep. 2021;:110218 pubmed publisher
|
Sefik E, Israelow B, Mirza H, Zhao J, Qu R, Kaffe E, et al. A humanized mouse model of chronic COVID-19. Nat Biotechnol. 2021;: pubmed publisher
|
Sun M, Zhang H, Jiang M, Chai Y, Qi J, Gao G, et al. Structural insights into the cis and trans assembly of human trophoblast cell surface antigen 2. iScience. 2021;24:103190 pubmed publisher
|
Fu Y, Zhang Z, Yang Z, Jiang Y, Han X, Xu J, et al. CD27-CD38+ B cells accumulated in early HIV infection exhibit transitional profile and promote HIV disease progression. Cell Rep. 2021;36:109344 pubmed publisher
|
Del Alcazar D, Wang Y, He C, Wendel B, Del Rio Estrada P, Lin J, et al. Mapping the Lineage Relationship between CXCR5+ and CXCR5- CD4+ T Cells in HIV-Infected Human Lymph Nodes. Cell Rep. 2019;28:3047-3060.e7 pubmed publisher
|